Neuropathology of suicide: a narrative review article
Open Access
- 29 July 2024
- journal article
- Published by African Journals Online (AJOL) in East African Journal of Neurological Sciences
- Vol. 3 (2) , 89-100
Abstract
Suicide neuropathology is a multifactorial phenomenon influenced by psychological, social, and environmental factors. Researchers have primarily focused on the role of neurotransmitters, such as serotonin, in suicide. A deficiency in serotonin input to the anterior cingulate cortex and ventral prefrontal cortex is associated with suicide and suicidal behaviour and is linked to decision-making and suicide intent. The serotonin hypothesis proposed that low levels of serotonin in the brain contribute to an increased risk of suicidal behaviour. However, subsequent studies have produced mixed and inconsistent results, indicating that the relationship between serotonin and suicide is not straightforward. Recent research has expanded the focus to structural and functional brain abnormalities associated with suicidal behaviour. Advances in neuroimaging techniques have allowed researchers to investigate the brain's anatomy, connectivity, and activity patterns in individuals at risk of suicide. Genetic studies have provided insights into the genetic basis of suicide risk, with certain genetic variations associated with increased susceptibility to suicidal behaviour. Studies have found increased levels of pro-inflammatory markers in the brains of individuals who died by suicide, suggesting a link between inflammation and suicide risk. A drug targeting the glutamate pathway, ketamine, has recently drawn attention for its ability to rapidly treat depressive symptoms and holds great promise as a potential antisuicidal drug. Overall, further research is needed to better understand the neuropathological mechanisms underlying suicidal behaviour.Keywords
This publication has 21 references indexed in Scilit:
- Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk FactorsBiological Psychiatry, 2021
- Neuropathology of suicide: recent findings and future directionsMolecular Psychiatry, 2017
- Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibitionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2017
- The neurobiology of suicideThe Lancet Psychiatry, 2014
- Positron Emission Tomography Quantification of Serotonin Transporter in Suicide Attempters with Major Depressive DisorderBiological Psychiatry, 2013
- Amygdalar expression of proteins associated with neuroplasticity in major depression and suicideJournal of Psychiatric Research, 2013
- Cholesterol and phospholipids in frontal cortex and synaptosomes of suicide completers: Relationship with endosomal lipid trafficking genesJournal of Psychiatric Research, 2013
- Can biological tests assist prediction of suicide in mood disorders?International Journal of Neuropsychopharmacology, 2005
- Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporterJournal of Psychiatric Research, 2003
- Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depressionBiological Psychiatry, 1999